Objective-Angiogenesis and inflammation are closely related processes. Gremlin is a novel noncanonical vascular endothelial growth factor receptor-2 (VEGFR2) ligand that induces a proangiogenic response in endothelial cells (ECs). Here, we investigated the role of the cyclic adenosine monophosphate-response element (CRE)-binding protein (CREB) in mediating the proinflammatory and proangiogenic responses of ECs to gremlin. Approach and Results-Gremlin induces a proinflammatory response in ECs, leading to reactive oxygen species and cyclic adenosine monophosphate production and the upregulation of proinflammatory molecules involved in leukocyte extravasation, including chemokine (C-C motif) ligand-2 (Ccl2) and Ccl7, chemokine (C-X-C motif) ligand-1 (Cxcl1), vascular cell adhesion molecule-1 (VCAM-1), and intercellular adhesion molecule-1 (ICAM-1). Accordingly, gremlin induces the VEGFR2-dependent phosphorylation, nuclear translocation, and transactivating activity of CREB in ECs. CREB activation mediates the early phases of the angiogenic response to gremlin, including stimulation of EC motility and permeability, and leads to monocyte/macrophage adhesion to ECs and their extravasation. All these effects are inhibited by EC transfection with a dominant-negative CREB mutant or with a CREB-binding protein-CREB interaction inhibitor that competes for CREB/CRE binding. Also, both recombinant gremlin and gremlin-expressing tumor cells induce proinflammatory/proangiogenic responses in vivo that are suppressed by the anti-inflammatory drug hydrocortisone. 
A ngiogenesis and inflammation are closely integrated processes. [1] [2] [3] Inflammatory cells may produce angiogenic cytokines, growth factors, and proteases that contribute to the formation of new vascular structures at the site of inflammation, tissue damage, or tumor growth. 3, 4 Moreover, several proinflammatory cytokines may induce blood vessel formation via direct engagement of target endothelial cells (ECs) or indirectly by inducing leukocytes and ECs to produce proangiogenic mediators. [5] [6] [7] However, angiogenic factors, such as vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang-1), and fibroblast growth factor-2 (FGF2), may elicit proinflammatory responses in ECs by upregulating the expression of cell adhesion molecules and inflammatory mediators involved in leukocyte recruitment and activation. [8] [9] [10] Thus, neovascularization and inflammation share several common signaling pathways and molecular mediators.
The cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB) is a bZip transcription factor that forms homodimers or heterodimers with other CREB or activating transcription factor (ATF) family members and binds to specific cAMP-response element (CRE) promoter sites to regulate the transcription of numerous genes. 11 Several lines of evidence implicate CREB activation in angiogenesis and inflammation. CREB regulates the expression of several genes induced by hypoxia, such as VEGF 12, 13 and its receptor. 14, 15 Also, overexpression of a constitutively active form of CREB enhances tumor angiogenesis. 16 Conversely, VEGF induces CREB phosphorylation in ECs, thus increasing its transcriptional activity. 16, 17 This capacity is shared by other angiogenic growth factors, including FGF2 and hepatocyte growth factor. 18, 19 However, cyclooxygenase-2 upregulation induced by inflammatory cytokines in ECs as well as various pattern recognition receptor responses are mediated by CREB activation. diseases 24 and cancer. [25] [26] [27] Gremlin acts as a bone morphogenic protein (BMP) antagonist by binding BMP2, BMP4, and BMP7. 28 Also, gremlin stimulates EC intracellular signaling and motility in a BMP-independent manner, leading to a potent angiogenic response in vivo. 27, 29 This is because of the capacity of gremlin to bind and activate VEGF receptor-2 (VEGFR2), the main transducer of VEGF-mediated angiogenic signals. 30, 31 Also, gremlin interacts with heparan-sulfate proteoglycans that act as functional gremlin coreceptors in ECs, affecting its productive interaction with VEGFR2. 32 However, at variance with heparin-binding VEGFs, gremlin does not interact with the coreceptor neuropilin-1. 32 Thus, gremlin is a novel proangiogenic VEGFR2 agonist distinct from canonical VEGFs.
Here, we demonstrate that gremlin induces a proinflammatory response in ECs by inducing the expression of various chemokines and cell adhesion molecules, causing a VEGFR2-mediated activation of CREB. In turn, CREB activation mediates the early phases of the angiogenic response to gremlin, including stimulation of EC motility and permeability, and leads to leukocyte-adhesion to ECs and their extravasation. In keeping with these observations, gremlin and gremlin-expressing tumor cells induce a proinflammatory or proangiogenic response in vivo that is suppressed by the anti-inflammatory drug hydrocortisone. These data point to a nonredundant role of CREB in mediating the EC response to gremlin and underline the tight cross-talk between angiogenesis and inflammation.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Gremlin Induces a Proinflammatory Response in ECs
Gremlin induces a potent angiogenic response in vitro and in vivo. 27, 30, 33 To get further insights on the proangiogenic activity of gremlin, we assessed the transcriptional profile of murine microvascular ECs (SIECs) stimulated by recombinant gremlin using Affymetrix MG-U74Av2 genechips (consisting of 22 690 probe sets, corresponding to ≈15 000 genes). A preliminary analysis of the data indicates that a noticeable group of gremlin-induced genes was related to the inflammatory response, including various cytokines, chemokines, and leukocyte-adhesion molecules (Andres, article in preparation).
To confirm these observations, serum-starved SIECs were stimulated with recombinant gremlin and investigated by quantitative real time polymerase chain reaction analysis for the expression of the monocyte/macrophage chemotactic chemokine (C-C motif) ligand-2 (Ccl2) and Ccl7, the neutrophil chemoattractant chemokine (C-X-C motif) ligand-1 (Cxcl1) and of the cell adhesion molecules vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1). Time-course analysis demonstrates the capacity of gremlin to induce an early upregulation of all the genes investigated, thus confirming its ability to induce a proinflammatory response in ECs. Similar results were obtained when SIECs were stimulated with the proangiogenic canonical VEGFR2 ligand VEGF-A 165 ( Figure I in the online-only Data Supplement). In keeping with their capacity to trigger a proinflammatory response in ECs, gremlin and VEGF-A 165 stimulated also the production of cAMP and of reactive oxygen species (Figure II in the online-only Data Supplement).
Gremlin Induces CREB Activation in ECs
CREB activation has been implicated in the regulation of growth factor-mediated inflammatory and vascular remodeling responses. 16 In SIECs, gremlin induces a dose-dependent phosphorylation of CREB (on Ser-133) and its rapid nuclear translocation ( Figure 1A and 1B). This was paralleled by phosphorylation (on Ser-66) and nuclear translocation of the cross-reacting family member ATF-1 34 and was preceded by the phosphorylation and nuclear translocation of extracellular signal-regulated protein kinases 1 and 2 (ERK 1/2 ; Figure 1B) . Similar results were obtained by immunofluorescence analysis of SIECs that showed a perinuclear pCREB immunoreactivity on 10 minutes of stimulation with gremlin and a nuclear staining after 20 minutes ( Figure 1D ). In keeping with previous observations, 16, 17 CREB phosphorylation and nuclear translocation were observed also after SIEC stimulation by VEGF-A 165 ( Figure 1B and 1D ). This occurred with more rapid kinetics when compared with gremlin stimulation, possibly as a consequence of the different in-plane intermolecular attractive interactions after VEGFR2 recognition by the 2 ligands. 31 The capacity of gremlin to induce CREB activation was further assessed in starved human umbilical vein endothelial cells (HUVECs) exposed to gremlin for 0 to 60 minutes by electrophoretic mobility shift assay using a biotin-labeled CRE oligonucleotide probe. As anticipated, gremlin induces the formation of the CREB/CRE complex in a time-dependent manner ( Figure 1C ). Complex formation was significantly inhibited by a 100-fold excess of the unlabeled CRE probe, but not of an unlabeled mutated probe; also, incubation with an anti-CREB antibody caused the supershift of the complex ( Figure 1C ). Finally, we established an in situ CREB/DNA-binding assay to visualize the CRE-binding activity of CREB directly in cells or tissue sections (see Materials and Methods section in the online-only Data Supplement). To this purpose, gremlin-treated HUVECs were fixed, permeabilized, and incubated for 1 hour with a Cy5-labeled oligoprobe containing the palindromic or the mutated CRE sequence. As shown in Figure 1E , the Cy5-labeled palindromic CRE oligoprobe binds the nuclear CREB of gremlin-stimulated cells, whereas the mutated oligoprobe 
VEGFR2 Mediates CREB Activation by Gremlin in ECs
Gremlin is a noncanonical ligand of the major proangiogenic receptor VEGFR2 without exerting any interaction with VEGFR1. 30 To assess whether the capacity of gremlin to induce CREB activation is attributable to a VEGFR2-mediated effect, SIECs were pretreated with the tyrosine kinase VEGFR2 inhibitor SU5416 30 and incubated for 15 minutes with gremlin. As shown in Figure 2A , SU5416 fully prevents CREB activation as assessed by ELISA, thus confirming that CREB activation is part of the VEGFR2-mediated proangiogenic response elicited by gremlin in ECs. Relevant to this point, gremlin induces CREB phosphorylation also in VEGFR2-expressing smooth muscle cells with no effect on VEGFR1-expressing peripheral blood mononuclear cells ( Figure III in the online-only Data Supplement).
As described above, ERK 1/2 phosphorylation precedes CREB activation in gremlin-treated ECs (see Figure 1B) . A 60-minute preincubation with the MAP kinase kinase inhibitor PD98059, 12 the p38 mitogen activated protein kinase inhibitor SB202190, 12 or the Src inhibitor PP2 12 all prevent CREB phosphorylation and DNA binding triggered by gremlin (Figure 2A and 2B) .
Together, these data indicate that activation of the mitogen activated protein kinase pathway after VEGFR2 engagement plays a pivotal role in CREB activation by gremlin in ECs.
CREB Mediates the Early Phases of the Angiogenic Response of ECs to Gremlin
Increased permeability and acquisition of a promigratory phenotype are among the earliest events that occur in ECs after stimulation by proangiogenic factors, including VEGF. Accordingly, previous observations had shown that gremlin elicits a motogenic response in ECs both when administered as a recombinant protein or when produced by gremlin-overexpressing tumor cells. 33 However, no data were available about a possible effect of gremlin on EC permeability.
Here, confluent HUVEC monolayers plated on Transwell membrane support were treated for 24 hours with the conditioned medium from human breast carcinoma MCF7 cells stably transfected with the human gremlin cDNA (gremlin-MCF7 cells) or with the empty vector (mock-MCF7 cells). 33 Then, 50 μg of biotin-labeled bovine serum albumin were added to the upper Transwell chamber, and the amount of bovine serum albumin diffused to the lower chamber through the HUVEC monolayer was quantified after 90 minutes. Gremlin significantly affects HUVEC permeability, as demonstrated by the 2-fold increase of biotin-labeled bovine serum albumin detectable in the lower wells treated with the conditioned medium from gremlin-MCF7 cells when compared with mock cells ( Figure 3A ). The loss of EC barrier integrity was confirmed by immunofluorescence analysis of gremlin-treated HUVEC monolayers using antibodies against the major endothelial adherens junction protein vascular endothelial-cadherin and the tight junction-associated protein zonula occludens ZO-1. When compared with control cells, cells treated with gremlin were characterized by an increased number of intercellular gaps and by the delocalization of vascular endothelial-cadherin and ZO-1 from the cell junctions to the cytoplasm ( Figure 3B ). Similar to that described for VEGF-A 165 , 35 the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) prevented EC junction disruption in gremlin-stimulated cells ( Figure IV in the online-only Data Supplement). In agreement with these observations, both recombinant gremlin and VEGF-A 165 similarly affected blood vessel permeability in vivo when tested subcutaneously (s.c.) in the Miles assay 36 ( Figure 3C and Cʹ).
Inhibition of CREB activation after transient transfection with the dominant-negative bZIP domain mutant ACREB 37 ( Figure 3Aʹ ) prevents the increase of permeability induced by gremlin in HUVECs ( Figure 3A) . Similarly, ACREB overexpression significantly inhibited the chemokinetic response elicited by gremlin or VEGF-A 165 in HUVECs as assessed by time-lapse video microscopy ( Figure 3D ) and the chemotactic activity exerted by gremlin on SIECs in a Boyden chamber assay (Figure VA in the online-only Data Supplement). Accordingly, a CRE-decoy 24-mer oligonucleotide 38 caused a dramatic reduction of the chemotactic response of HUVECs to gremlin (Figure VB in the online-only Data Supplement) with no effect on their adhesive capacity (data not shown).
These data point to a functional role of CREB in the early phases of the angiogenic response to gremlin by affecting EC permeability and motility.
Gremlin Causes CREB-Dependent Leukocyte Extravasation
Leukocyte infiltration is a common feature of inflammation, angiogenesis, and cancer. It involves a sequence of VCAM-1 and ICAM-1-mediated adhesive events between leukocytes and endothelial receptors that culminates in leukocyte extravasation. 39 Previous observations had shown a direct or indirect role of CREB in mediating VCAM-1 and ICAM-1 upregulation in ECs. 37, 38, 40 To assess whether CREB activation is involved in the modulation of VCAM-1 and ICAM-1 expression by gremlin, mock-and ACREB-transfected HUVECs were treated with the conditioned medium from mock-or gremlin-MCF7 cells. After 24 hours, ICAM-1 and VCAM-1 transcript and protein levels were assessed by quantitative real time polymerase chain reaction and flow cytometry analysis, respectively. As shown in Figure 4A and 4B, ACREB overexpression hampered ICAM-1 and VCAM-1 upregulation triggered by gremlin with no effect on the expression of other EC genes, for example, platelet endothelial cell adhesion molecule-1. Similarly, ACREB overexpression prevented ICAM and VCAM-1 upregulation triggered by VEGF-A 165 in ECs (Figure VI in the online-only Data Supplement).
Given the role of ICAM-1 and VCAM-1 in mediating monocyte-EC adhesion and transmigration, we evaluated the adhesion of human monocytic THP-1 cells to gremlin-treated ECs. To this purpose, mock-and ACREB-transfected HUVECs were stimulated for 24 hours with the conditioned medium from mock-MCF7 or gremlin-MCF7 cells and incubated for 1 hour with LPS-activated THP-1 cells. The results demonstrate that gremlin significantly increases THP-1 cell adhesion to the EC monolayer (77±17 versus 135±15 cells/field for control and gremlin-treated cells, respectively). As anticipated, this increase was prevented by coincubation with neutralizing monoclonal antibodies against ICAM-1 or VCAM-1, as well as by transient ACREB transduction in HUVECs ( Figure 4C ). Similar results were obtained when mock and ACREBHUVECs were stimulated with recombinant gremlin or VEGF-A 165 ( Figure VII in the online-only Data Supplement).
Next, we evaluated the effect of endothelial CREB activation by gremlin on leukocyte diapedesis. Mock-and ACREBtransfected HUVECs were plated on a Transwell membrane support and cocultured with mock-MCF7 or gremlin-MCF7 cells seeded in the lower chamber. After 24 hours, LPS-activated THP-1 cells were added to the upper chamber in the absence or in the presence of neutralizing anti-ICAM-1 or anti-VCAM-1 antibodies and allowed to transmigrate for the next 16 hours. The amount of THP-1 cells transmigrated throughout the HUVEC monolayer was 6-fold higher in the presence of gremlin-MCF7 cells in the lower chamber than in the presence of mock-MCF7 cells. Also, THP-1 cell transmigration was prevented by neutralizing anti-ICAM-1 or anti-VCAM-1 antibodies. Moreover, inhibition of CREB activation in HUVECs by ACREB transduction significantly reduced THP-1 adhesion and transmigration ( Figure 4D ). It must be pointed out that, in the absence of the HUVEC monolayer, THP-1 cells showed a similar, limited migratory response toward mock-MCF7 and gremlin-MCF7 cells (data not shown). This observation suggests that THP-1 cell transmigration is driven by a gremlin-induced chemotactic stimulus of EC origin rather than a direct chemotactic effect. Indeed, as described above, gremlin upregulates the expression of a variety of chemokines in ECs that may be responsible for the observed THP-1 cell recruitment. In keeping with this hypothesis, gremlin-driven THP-1 cell transmigration through the HUVEC monolayer was significantly reduced by the pan-chemokine inhibitor M3, a murine γ-herpesvirus 68 protein antagonist for human and mouse CC, CXC, and CX3C chemokines 41 ( Figure VIII in the online-only Data Supplement). Together the data indicate that gremlin stimulates monocyte transmigration by acting on ECs and inducing the coordinate upregulation of chemokine production and the CREB-dependent expression of the cell adhesion molecules VCAM-1 and ICAM-1 on the EC surface. This is paralleled by increased CREB-dependent EC permeability and acquisition of a motile phenotype.
On this basis, we evaluated the capacity of gremlin to induce a CREB-dependent leukocyte extravasation in vivo. In a first set of experiments, CREB activation by gremlin was assessed in the chick embryo chorionallantoide membrane (CAM) by the in situ CREB/DNA-binding assay described above. To this aim, CAMs were treated with gremlin (100 ng/implant) for 20 minutes. Then,
Figure 3. cAMP-response element-binding protein (CREB) modulates gremlin-induced endothelial cell (EC) permeability and motility.
A, Mock-and ACREB-human umbilical vein endothelial cells (HUVECs) were plated at confluence on Transwell and treated with the conditioned medium from mock-MCF7 or gremlin-MCF7 cells for 24 hours. To measure EC permeability, biotin-bovine serum albumin (BSA) was added to the top chamber at 50 μg/well. After 90 minutes, the top chamber was removed, and biotin-BSA was measured in the lower chamber with horseradish peroxidase-conjugated streptavidin. A′, Twenty-microgram aliquots of mock and ACREB-HUVEC lysates were probed by Western blotting with anti-CREB antibodies. B, Confluent HUVECs were incubated with vehicle or 50 ng/mL of gremlin, fixed with 3% paraformaldehyde, and permeabilized with 0.2% Triton X-100. Then, cells were incubated with anti-zonula occludens (ZO)-1 or antivascular endothelial-cadherin (VE-Cad) antibodies followed by anti-mouse Alexa 488 and nuclei were counterstained with 4',6-diamidino-2-phenylindole. Analysis was performed using a Zeiss Axiovert 200M epifluorescence microscope equipped with Apotome system and a Plan-Apochromat 63x/1.4 NA oil objective. Note that the cell-cell contact localization of ZO-1 and VE-Cad is lost in gremlin-treated cells. C, Systemic (i.v.) administration of Evans blue in C57BL6 mice was followed by intradermal injection of vehicle or 50 ng of gremlin or vascular endothelial growth factor-A (VEGF-A 165 ). Evans blue leakage was assessed after 20 minutes (representative images are shown in C′), and quantification of extravasated dye was assessed by formamide extraction. D, Mock and ACREB-HUVECs were seeded in M199 plus 5% fetal calf serum. Then, cells were stimulated with 50 ng/mL of gremlin or VEGF-A 165 , and cell motility was assessed by time-lapse videomicroscopy using an inverted photomicroscope (Zeiss Axiovert 200M) equipped with an LD A PLAN 20X/0,30PH1 objective. Constant temperature (37°C) and PCO 2 (5%) were maintained throughout the experimental period by means of heatable stage and climate chamber. Phase-contrast snap photographs were digitally recorded for 240 minutes. Cell paths (15-20 cells per experimental point) were generated from centroid positions, and migration parameters were analyzed with the Chemotaxis and Migration Tool of ImageJ Software (http://rsbweb.nih.gov/ij). Accumulated distances (in μm) are shown in D. *P<0.05; Student t test.
frozen tissue sections were incubated with the Cy5-labeled palindromic CRE oligoprobe and analyzed by immunofluorescence microscopy. As shown in Figure 5A , the Cy5-labeled palindromic CRE oligoprobe binds EC nuclei in gremlin-stimulated CAMs but not in control CAMs. The specificity of interaction was confirmed by the lack of nuclear staining when gremlin-treated CAMs were incubated with a Cy5-oligoprobe containing a mutation in the CRE sequence. These observations further confirm that CREB is a downstream molecule activated in vivo by gremlin in ECs. Next, alginate beads loaded with gremlin or VEGF-A 165 were implanted onto the CAMs at 11 days of development. As anticipated, both gremlin and VEGF-A 165 triggered the recruitment of a robust inflammatory cell infiltrate in the CAM stroma that was prevented by the topic administration of a CREB-binding protein-CREB interaction inhibitor that suppresses the transcriptional activity of CREB 42 ( Figure 5B and 5C).
Gremlin-Expressing Tumor Cells Induce a Proinflammatory/Proangiogenic Response In Vivo
To get further insights on the role of inflammation in gremlin-driven neovascularization, we compared the capacity of gremlin and VEGF-A 165 to induce a proangiogenic response in the classical in vivo murine Matrigel plug angiogenesis assay 43 in the presence of the anti-inflammatory drug hydrocortisone. After 7 days, immunofluorescence and quantitative real time polymerase chain reaction analyses of the plugs 43 revealed a significant increase of the expression of the endothelial marker CD31 and of the pan-leukocyte marker CD45 both in gremlin and VEGF-A 165 plugs when compared with control plugs ( Figure 6A ). As anticipated, hydrocortisone prevented the recruitment of infiltrating cells and the neovascular response triggered by both VEGFR2 ligands ( Figure 6B ).
Gremlin is expressed by tumor and stromal cells in different human cancers. 26 On this basis, alginate beads loaded with the conditioned medium from mock-MCF7 or gremlin-MCF7 cells were implanted onto the CAMs. Similar to recombinant gremlin or VEGF-A 165 , the conditioned medium of gremlin-MCF7 cells induced a potent angiogenic response ( Figure Next, we assessed the effect of gremlin in a tumor angiogenesis assay. To this purpose, Matrigel embedded mock-MCF7 or gremlin-MCF7 cells were implanted s.c. in nu/ nu male mice. Anti-nitro-tyrosine immunostaining of the implants performed at day 7 after injection demonstrates that gremlin-MCF7 cells induce NO production in tumor grafts ( Figure 7A ). Accordingly, gremlin-MCF7 xenografts were characterized by the presence of several CD31-positive blood vessels and of an abundant CD45-positive leukocyte infiltrate when compared with mock-MCF7 implants as shown by immunofluorescence and quantitative real time polymerase chain reaction analyses ( Figure 7B and 7C) . A further characterization of infiltrating cells showed that recruited leucocytes mainly consist of mature F4/80 + macrophages and CD11b + monocytes with rare neutrophils ( Figure 7B) . Again, the administration of hydrocortisone prevented the inflammatory response and neovessel formation triggered by gremlin-MCF7 xenografts ( Figure 7A-7C) . Together, our findings support the notion that inflammatory responses are relevant for gremlindependent neovascularization.
Discussion
Neovascularization and inflammation share common signaling pathways and molecular mediators. Several proinflammatory cytokines may induce blood vessel formation via a direct engagement of target ECs or indirectly by inducing leukocytes and ECs to produce proangiogenic mediators. 44 Conversely, angiogenic factors may elicit a proinflammatory signature in ECs, 10, 45 causing the upregulation of cell adhesion molecules and inflammatory mediators that leads to the recruitment of proangiogenic leukocytes at the site of injury. Here, we show that the proangiogenic activity of gremlin is dependent on its direct effect on EC behavior and on its ability to affect the modulation of proinflammatory mediators in ECs.
Previous observations had shown that gremlin triggers VEGFR2-mediated intracellular signals that lead to in vitro EC sprouting and invasive activity and in vivo neovessel formation. 30, 32 Here, we show that gremlin also exerts a proinflammatory response in ECs inducing NO production and an increase of intracellular cAMP levels that lead to EC permeability and CREB activation, respectively. Accordingly, a preliminary transcriptome analysis of gremlin-treated ECs points to the capacity of this factor to induce a proinflammatory signature in endothelium by causing the upregulation of various inflammatory cytokines, chemokines, and leukocyteadhesion molecules (Andres, article in preparation). All these molecules concur to leukocyte extravasation. Here, we have confirmed this observation by showing that gremlin stimulates monocyte transmigration by acting on ECs and inducing the coordinate upregulation of the monocyte/macrophage and neutrophil chemotactic chemokines Ccl2, Ccl7, and Cxcl1 and the expression of the cell adhesion molecules VCAM-1 and ICAM-1 on the EC surface. This is paralleled by increased EC permeability and acquisition of a motile phenotype.
All these effects were inhibited by transient transfection of ECs with a dominant-negative CREB mutant and by a CREdecoy oligonucleotide. Indeed, gremlin causes CREB activation, nuclear translocation, and DNA binding in ECs through a productive gremlin-VEGFR2 interaction. PI-3K and PKC mediate CREB activation after VEGFR2 engagement by VEGF-A. 12, 17 Our observations demonstrate a nonredundant role of VEGFR2-mediated mitogen activated protein kinase and Src signaling in CREB activation by gremlin, whereas no effect was exerted by the PI-3K inhibitors LY294002 and Wortmannin or the PKC inhibitor GF109203X (data not shown). Together with the different kinetics of CREB activation by the 2 factors, these data reveal the previously unrecognized capacity of gremlin to trigger VEGFR2-dependent intracellular events distinct from those elicited by VEGF-A. This is in keeping with the different nanomechanical affinity of the 2 ligands for VEGFR2 because of different surface intermolecular interactions that may lead to distinctive EC responses (see reference 31 for a further discussion of this point).
Vascular permeability can be regulated by growth factors such as VEGF as well as by a wide array of inflammatory mediators via distinct molecular processes. 46 Here, we show that CREB activation by gremlin, either when administered as a recombinant protein or when produced by tumor cells, drives the breakdown of EC barrier function in vitro and in vivo, paralleled by the redistribution of the major endothelial adherens junction protein vascular endothelial-cadherin and the tight junction-associated protein ZO-1, thus allowing protein diffusion through the EC monolayer and leukocyte transendothelial migration. Also, in keeping with the critical role of NO in modulating vascular permeability, 47 the NO-synthase inhibitor L-NAME hampers EC junction disassembly after gremlin stimulation. Moreover, we cannot rule the possibility that additional factors produced by gremlin-stimulated ECs may concur with gremlin in inducing vascular leakage. Further experiments are required to fully elucidate the mechanisms leading to gremlin-mediated EC permeability.
The upregulation of ICAM-1 and VCAM-1 in cytokineactivated ECs may occur via CREB activation as well as via the activation of the transcription factor NF-κB. 40, 41 Indeed, NF-κB triggers a proinflammatory/proangiogenic transcription program in endothelium and regulates the production of various angiogenic factors 48 pointing to a tight cross-talk between NF-κB and CREB activity during inflammation. 49 Previous observations had shown the ability of gremlin to induce NF-κB activation in ECs, leading to Ang-1 upregulation. 50 Here, we demonstrate the role of CREB in the modulation of ICAM-1 and VCAM-1 expression in gremlin-activated ECs and its involvement in monocyte/macrophage transendothelial migration. Of note, EC treatment with the cAMP analogous dibutyryl-cAMP fails to recapitulate the proinflammatory response elicited by gremlin ( Figure X in the onlineonly Data Supplement). Together, the data raise the possibility that NF-κB may concur with CREB activation in driving the proinflammatory phenotype triggered by gremlin in ECs. However, the capacity of gremlin to induce the activation of 2 major proinflammatory transcription factors in ECs underlines the role of inflammation in the neovascularization process. This is confirmed by the ability of the anti-inflammatory drug hydrocortisone to hamper the angiogenic activity exerted in vivo by gremlin or gremlin-overexpressing tumor cells.
Gremlin may exert a dual role in different physiological and pathological conditions by acting as a BMP antagonist and as a noncanonical VEGFR2 ligand. For example, gremlin seems to play BMP-independent angiogenic and tumorigenic functions in different neoplasms 25, 26 and to promote tumor epithelial-to-mesenchymal transition by inhibiting BMP signaling. 51 Although its contribution to neovascularization and tumor growth in experimental and human neoplasms deserves further investigation, our data support the notion that gremlin produced by tumor cells may induce angiogenesis by interacting directly with ECs and by stimulating the recruitment of a proangiogenic inflammatory infiltrate. Accordingly, previous observations have shown that gremlin upregulation may play a pathogenic role in different chronic inflammatory conditions, including hypoxic pulmonary hypertension, 52 diabetic nephropathy, 53 and lung fibrosis. 54 Indeed, gremlin haplodeficiency reduces vascular remodeling in hypoxic lung and diabetes mellitus-associated kidney damage. 55 However, gremlin attenuates atherosclerotic plaque growth in ApoE − / − mice 56 and may act as neuroprotective factor for dopamine neuron degeneration. 57 Thus, the biological impact of gremlin downregulation or of its overexpression in different pathological settings seems to be strictly contextual.
In conclusion, our data point to a nonredundant role of CREB in mediating the EC response to gremlin and underline the tight cross-talk between angiogenesis and inflammation ( Figure XI in the online-only Data Supplement). The capacity of gremlin to activate a proinflammatory or proangiogenic phenotype in endothelium may contribute to neovascularization and activation of innate immune responses in different pathological conditions, including fibrosis and cancer.
